Veljko Vlaisavljević. Overview



Similar documents
Etienne Van den Abbeel

Fast Track to IVF. Objectives

Preimplantation genetic screening (PGS)

Midland Fertility Services Blastocyst Transfer

Guide to IVF Laboratory Results

Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register

Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY

How To Get A Refund On An Ivf Cycle

AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG.

European IVF Monitoring (EIM) Year: 2008

Assisted Reproductive Technologies at IGO

A POWERFUL IN VITRO FERTILIZATION

Training Programme in. Assisted Reproductive Technologies:

Center for Women s Reproductive Care at Columbia University

Ehlers-Danlos Syndrome Fertility Issues. Objectives

IVF MONEY-BACK PLAN IN PARTNERSHIP WITH

IVF OVERVIEW. Tracy Telles, M.D.

REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN (651)

Project proposal. Reproductive tourism in India: A description of surrogate mothers and their offspring. Medical student Malene Tanderup Kristensen

NON MEDICARE FEES CANBERRA FERTILITY CENTRE VERSION JANUARY 2015 AM QWB 295

INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION OF PREVIOUSLY CRYOPRESERVED OOCYTES

Guidelines for the Number of Embryos to Transfer Following In Vitro Fertilization

Clinical Reference Group Quality & Safety Committee Governing Body. Policy Screened

Clinical Policy Committee

Preimplantation Genetic Diagnosis (PGD) for Fanconi Anemia and HLA matching

Consent to Perform Preimplantation Genetic Screening (PGS) using. Comparative Genomic Hybridization (acgh) or Next Generation Sequencing (NGS)

Assisted reproductive technology in Australia and New Zealand 2010

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)

European IVF Monitoring (EIM) Year: 2010

Oocyte Donation in Spain

Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in Cases of Habitual Abortions

Preimplantation genetic diagnosis new method of screening of 24 chromosomes with the Array CGH method...2

Tower Hamlets CCG Fertility policy

Money-back guarantee,

London Fertility Centre Price List

Metformin treatment before IVF / ICSI in non obese PCOS women

In Vitro Fertilization (IVF) Page 1 of 11

The relevant NICE Clinical Guidance 156, Fertility can be accessed here:

Why. IVF Centers Prof. Zech. fertility treatment? for your. choose the

OUR IVF/ICSI PROGRAMME

In - Vitro Fertilization Handbook

Transitioning from IVF practice to restorative reproductive medicine.

Fertility Research Policy

Fertility care for women diagnosed with cancer

CONSENT TO PARTICIPATE IN THE IN VITRO FERTILIZATION-EMBRYO TRANSFER PROGRAM

MASSACHUSETTS GENERAL HOSPITAL VINCENT REPRODUCTIVE MEDICINE AND IVF

Management fertility sparing degli endometriomi Errico Zupi

East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception. December 2014

FERTILITY AND AGE. Introduction. Fertility in the later 30's and 40's. Am I fertile?

Preimplantation Genetic Diagnosis (PGD) in Western Australia

Endocrinology of the Female Reproductive Axis

Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics. January 2006

50% Off Cycle 3 $ 9,900 $ 8,700 $ 7,500

Article. Laura Detti, MD, Frank D. Yelian, MD, PhD, Michael L. Kruger, MA, Michael P. Diamond, MD, Elizabeth E. Puscheck, MD

Authorized By: Holly C. Bakke, Commissioner, Department of Banking and Insurance.

Nordic Fertility Society. Quality Guide. Checklist for ART Clinic and ART laboratory

Outline. Objective(s) Background. Methods. Results. Discussion. Questions

World Collaborative Report on Assisted Reproductive Technology, 2002

CONCEPT DOES NOT REQUIRE AN UP FRONT DEPOSIT (Except for Standard IVF/ICSI/FET where out of pocket costs must be paid in advance)

Welcome to chapter 2. The following chapter is called "Indications For IVF". The author is Dr Kamini A. Rao.

Informed Consent Packet - In Vitro Fertilization (IVF)

Consultations & other investigations

The following chapter is called "Follow-ups with a Positive or a Negative Pregnancy Test".

Setting new standards in IVF

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT FOR IN VITRO FERTILIZATION AND EMBRYO TRANSFER

Welcome to chapter 8. The following chapter is called "Monitoring IVF Cycle & Oocyte Retrieval". The author is Professor Jie Qiao.

DARTMOUTH-HITCHCOCK MEDICAL CENTER Lebanon, New Hampshire IN VITRO FERTILIZATION PROCEDURE DESCRIPTION

The Menstrual Cycle. Model 1: Ovarian Cycle follicular cells

Systematic review by: Dr. Ashraf Ahmed ElDaly, M.Sc., M.D.

The Menstrual Cycle, Hormones and Fertility Treatment

Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups

Revised minimum standards for in vitro fertilization, gamete intrafallopian transfer, and related procedures

Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy

Artificial insemination with donor sperm

IVF SUCCESS RATES. Cancellation Rates. Under Age 35: 0% cancellations, national average 7.1% Age 35 37: 2.0% cancellations national average 10.

SO, WHAT IS A POOR RESPONDER?

Consent for In Vitro Fertilization

The genetic screening of preimplantation embryos by comparative genomic hybridisation

Reproductive Technology. Chapter 21

Consent for Frozen Donor Oocyte In Vitro Fertilization and Embryo Transfer (Recipient)

Rationale for replacing IVIG with Intralipid (IL) for immunological pregnancy loss

Assisted Conception Policy. February Dr. Liz Saunders Cyril Haessig

PGS-NGS 360 Preimplantation Genetic Screening

Recent Progress in In Vitro Fertilization and Intracytoplasmic Sperm Injection Technologies in Japan

NWL CSU IFR Team CLINICAL COMMISSIONING GROUP BRIEFING. UPDATE OF THE PPwT POLICY ON IN-VITRO FERTILISATION (IVF)

HOW IS OVARIAN RESERVE ASSESSED?

Transcription:

21.January 2010, ESHRE Campus Maribor Day 2-3 versus Day 5 transfer advantages and disadvantages Veljko Vlaisavljević Department of Reproductive Medicine and Gynecologic Endocrinology University Clinical Centre Maribor Maribor, Slovenia E: ivf-mb@ukc-mb.si Overview Analysis of Cochrane data Why do we prefer to transfer blastocyst stage embryo? Analysis of retrospective, non-randomized comparison of day-2 ET versus day-5 ET Extended embryo culture in non stimulated cycles, poor, low and normal responders To evaluate the clinical efficacy of using day 5 embryo transfer for all patients Slow freezing or vitrification? Outcome of blastocyst transfers Dilemas Does the prolonged cultivation in in vitro conditions influence the embryo implantation capability? Is the five day cultivation the best approach for all patients (including patients with one oocyte or low responders)? Is the five day cultivation of any benefit in comparison with two day cultivation?

Dilemas - disadvantages Is extended embryo culture appropriate for all patients? Worldvide experience with blastocyst cryopreservation is not optimal? Higher rate of cancelled transfers ( having no embryos for transfer! ) Question of overall benefit of blastocyst culture (impacts on the final outcome?) Monozygotic twinning Dilemas - advantages Better synchronization between the embryo and the endometrium Better selection of viable embryos and higher implantation rate Increased risk of multiple gestation? Higher rate of cancelled transfers? The perfect embryo?? (based on morphology and development) Implantation of D5 embryo (SBT) in 49% patients 36 years Implantation of Day2 or Day3 embryo (SET) in 33 % of patients 36 years Papanikolaou et al., NEJM, 2006 Van Montfoort et al., Hum Reprod, 2006

Maribor blastocyst scoring system Kovacic B. et al. Reproductive BioMedicine Online 2004 Four morphologic parameters percentage of embryo, transformed to the blastocyst blastocoel expansion ICM shape in expanded blastocysts only trophectoderm cohesiveness and morphology Eight morphologic categories (B1 - B8) Implantation 1,0 0,8 0,6 0,4 0,2 0,0 Relationship between blastocyst morphology and implantation ability y=exp(0,332+(-0,304)*x)/(1+exp(0,332+(-0,304)*x)) 1 2 3 4 5 6 7 8 9 Morphology Birth rate declined from 45.2% to 7.7% from B1 to B8 quality blastocyst. Implantation capacity depending on blastocyst morphology characteristics. ti Birth rate declined from 45.2% to 7.7% from B1 to B8 quality blastocyst. Kovacic B. et al, Fertil Steril 2008 Day 2 vs. Day 5 embryo Randomized prospective trials Ongoing pregnancy rate Day 3 : 32.1% 95%CI 26.4-38.2% Day 5 : 33.2% 95%CI 27.3-39.5% Lower chance for cryopreservation ( 61.5% for D3 and 50.4% for D5, P<0.02) Kolibianakis et al., Hum Reprod.2004 Implantation rate: Day 2-3 embryos vs. day 5 blastocyst: 21.1% vs. 20.9% Hreinson et al. Eur J Obstet Gynecol Reprod Biol 2004 Day 3 vs. hatching blastocyst : 19.1% vs. 21.4 % Utsunomiya et al. Hum Reprod 2004 Elective single blastocyst : 60.9% Gardner et al. Fertil Steril 2004

Cochrane data (2009) Primary outcome ( live births per couple) Secondary outcome ( clinical pregnancy rate, multiple pregnancy rate, high order MPR, cryopreservation, failure to have any ET per couple ) Outcomes not appropriate for statistical analysis ( live births per OPU and ET, CPR/OPU&ET, implantation rate The Cochrane Metanalysis 2009 : Live birth rate Farquhar B.and Proctor J, The Cochrane Library 2009 Live birth rate per couple (2) Farquhar B.and Proctor J, The Cochrane Library 2009

Clinical pregnancy rate Farquhar B.and Proctor J, The Cochrane Library 2009 Miscarriage rate per couple Farquhar B.and Proctor J, The Cochrane Library 2009 Embryo cancellation rate

Cumulative pregnancy rate ( fresh & frozen transfers) eset in daily practice in Slovenia from 2008 Legal approach ( 3 embryos for ET from year 2000) Professional approach ( guidelines of national Society for Reproductive Medicine - 2 embryos for ET from year 2000) Reimbursement approach (reimbursement only according to guidelines for SET from year 2008) Retrospective analysis - IVF Maribor Retrospective analysis of 6056 stimulated and 391 nonstimulated cycles was performed Selection of embryos for blastocyst culture on day 3 BlastAssist System ( MediCult Denmark) Embryotransfer catetherer Labotect (Germany) No more than two blastocyst transferred at the time Surplus blastocyst freezed Blast Freez (MediCult,Denmark) Vitrification Kit (IrvineScientific, USA) Vaginal progesteron for luteal support Utrogestan (Iscovesco, France)

Patients selection strategy for blastocyst culture: NUMBER OF FOLLICLES OR OOCYTES Good responders on COH during the stimulation Patients with 5 oocytes and more after OPU Patients selection strategy for blastocyst culture: FERTILIZATION Patients with more than 4 fertilized oocytes Patients with more than three good quality embryos on day 3. Stimulated cycles # 6056 1 oocyte 2 4 oocytes 5 oocytes and more Cycles with fertilization 200 1299 4249 Delivery rate 6.5 % 18.4% 28.9 % Total fertilization failure : 308 cycles (5.1%)

Embryo transfer rate on Day 2 and Day 5 in patients younger than 40 er rate Embryo transfe 100 80 60 40 20 0 1 2 3 4 5 6 7 8 9 10+ Number of oocytes retrieved D2 D5 Results Non stimulated cycle Poor responders ( one oocyte) Low responders ( 2-4 oocytes) Normal responders ( 5 oocytes and more) Slow freezing and vitrification Nonstimulated cycles (#391) Day 3 ET Day 5 BT 204 187 Delivery rate per ET 23.8 % 40.0 % Delivery rate/cycle = 15.4 % Delivery rate/cycle = 14.3 %

ET on day 2 (204) ET on day 5 (187) p-value Oocyte recovery rate 79.4(162/204) 82.3 (154/187) NS Fertilization rate 73.8 (113/153) 77.7 (115/148) NS ET rate per aspiration 51.5 (105/204) 29.4 (55/187) <0.05 Pregnancy rate per ET 23.8 (25/105) 40.0 (22/55) <0.05 PR calculated /day 2 ET 23.8 (25/105) 22.2 (22/99) NS PR/ aspirated oocyte 15.4 (25/162) 14.3 (22/154) NS Number of D2 and D3 embryos required for transfer per baby born n=4934 N=443 10,00 6,6 6,8 5,00 0,00 Stimulated cycle Natural cycle Probability for implantation of a single embryo does not depend on cycle type (nonstimulated and stimulated cycles), but on morphologically assessed quality Vlaisavljevic et al. Hum Reprod 2001

Results Non stimulated cycle Poor responders ( one oocyte) Low responders ( 2-4 oocytes) Normal responders ( 5 oocytes and more) Slow freezing and vitrification Low responders (2-4 oocytes/opu) # 250 No BC for transfer esbt SBT edbt DBT TBT 62 (19.9 %) 12 113 22 101 2 Delivery rate 25.0 23.0 42.9 35.6 0.0 Multiple pregnancy rate = 32.1% Number of embryos required for transfer per baby born 10,00 66 6,6 68 6,8 5,00 2,8 0,00 Embryos Day 2&3 Natural Blastocyst 4934 443 2639

Embryo transfer rate per cycle was higher when day 2 embryos were transferred Expected pregnancy rate in poor responders calculated per embryo(s) available on day 2 is not affected by oocyte culture to the blastocyst stage. Results Non stimulated cycle Poor responders ( one oocyte) Low responders ( 2-4 oocytes) Normal responders ( 5 oocytes and more) Slow freezing and vitrification Normal responders (>4 oocytes/opu) # 3131 No BC for transfer esbt SBT edbt DBT TBT 224 (6.7%) 659 355 1135 957 125 Delivery rate 48.0 19.4 55.0 35.5 26.4 Multiple deliveries: 29.4 %

Implantation rate per cycle in single blastocyst transfer 60 tation rate Implant 50 40 30 20 10 0 22 24 26 28 30 32 34 36 38 40 42 44 Age (years) Implantation and delivery rate in cycles with good prognosis (892 fresh cycles with frozen spare blastocysts) 100 80 Implantation rate Rate R 60 40 20 0 Delivery rate 22 24 26 28 30 32 34 36 38 40 42 44 Age (years) Pregnancy rate per single (SBT) and double (DBT) blastocyst transfer Implantat tion rate 80 70 60 50 40 30 20 10 0 SBT DBT 22 24 26 28 30 32 34 36 38 40 42 44 Age (years)

Should the Double practice blastocyst of double blastocyst transfer transfer be abandoned? Vlaisavljevic et al., RBM Online, 2008;16:671. Vlaisavljevic et al. RBM Online 2008 Delivery rate per cycle after blastocyst transfers Delive ery rate 60 50 40 30 20 10 0 22 24 26 28 30 32 34 36 38 40 42 44 Age (years) Results Non stimulated cycle Poor responders ( one oocyte) Low responders ( 2-4 oocytes) Normal responders ( 5 oocytes and more) Slow freezing and vitrification

Number of blastocysts required for transfer per baby born 10,00 n=2956 14,4 n=834 5,00 2 0,00 2,9 Blastocyst (fresh) Frozen&towed blastocyst (slow freezing) Retrospective analysis of nonselective blastocyst slow freezing (n=667 cycles) At least 1 optimal blastocyst (n=317) Only nonoptimal blastocysts (n=350) Survival rate (%) 77.3 65.66 Transfers (%) 100 91.3 Transferred 1.6 ± 0.5 1.3 ± 0.7 blastocysts Positive beta hcg (%) 33.3 22.0 Ongoing pregnancies 19.7* 12.7 rate (%) Statistical significance: * * P<0.01 Elective single embryo transfer policy, Maribor 2008 Year before obligated implementation by insurance

Conclusion (1) Cochrane review 2009 Significant difference in live-birth rate per couple in favour of blastocyst transfer particulary in: a. Good prognosis patients b. Equal number of embryos transferred ( including single embryo transfer) c. Randomization after Day3 Rate of embryo freezing for couple was significantly higher on Day 2 to 3 transfers Failure to transfer any embryo was significantly higher in the blastocyst group, but not different in good prognosis patients. Conclusions (2) Necessary improvement of: patient selection embryo selection more successful cryopreservation programmes Implementation of prospective randomized studies is necessary to select effective strategies. Absence e of international standard procedures for eset may hinder full implementation of esbt. Conclusions (3) Same number of pregnancies with lower number of fresh transferred embryos? YES Major barriers for esbt seem to be: patients lack of knowledge. actual reimbursement system. cryopreservation technique? YES

In 2007 3.8% of all babies born in Slovenia were concieved by ART Reproductive Medicine Maribor Hospital: Veljko Vlaisavljević Vida Gavrić Lovrec Milan Reljič Vilma Kovač Lea Mlakar Polona Kores Testen Ksenija Rakić Marko Došen Nurses: Božena Rodeš Daniela Hanžel Marija Kristovič Jasna Muršič Marija Piperski ART Laboratory: Borut Kovačič Nina Hojnik Martin Ivec Barbara Breznik Martina Zafošnik Petra Robič Marjan Taborin Naca Herceg Secretary: Suzana Knuplež Marina Kokol